Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cell Source, Inc. | Director, 10%+ Owner | Common Stock | 4.41M | $3.31M | $0.75 | Jun 30, 2021 | Indirect |
Cell Source, Inc. | Director, 10%+ Owner | Director Stock Option (Right to Buy) | 300K | Aug 20, 2020 | Indirect | ||
Cell Source, Inc. | Director, 10%+ Owner | Series A Convertible Preferred Stock | 31.6K | May 7, 2019 | Indirect | ||
Cell Source, Inc. | Director, 10%+ Owner | Director Stock Option (Right to Buy) | 0 | Aug 20, 2020 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLCS | Cell Source, Inc. | Jun 30, 2021 | 1 | $14.6K | 4 | Jul 7, 2021 | Director, 10%+ Owner |
CLCS | Cell Source, Inc. | May 18, 2017 | 12 | $482K | 4 | Jun 10, 2021 | Director, 10%+ Owner |